Federal Preemption Claims: Clear Evidence and an Unclear Standard

Published date01 April 2016
Law FirmMorrison & Foerster LLP - Class Dismissed
AuthorErin M. Bosman,Austin Marsh,Julie Y. Park
Subject MatterBirth Defects,Failure To Warn,FDA,Labeling,Pharmaceutical Industry,Preemption,Prescription Drugs,Summary Judgment

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT